183 related articles for article (PubMed ID: 19356090)
1. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human.
Sahi J; Khan KK; Black CB
Drug Metab Lett; 2008 Aug; 2(3):176-83. PubMed ID: 19356090
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Strelevitz TJ; Orozco CC; Obach RS
Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
[TBL] [Abstract][Full Text] [Related]
3. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
[TBL] [Abstract][Full Text] [Related]
4. Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382.
Hutzler JM; Cerny MA; Yang YS; Asher C; Wong D; Frederick K; Gilpin K
Drug Metab Dispos; 2014 Oct; 42(10):1751-60. PubMed ID: 25035284
[TBL] [Abstract][Full Text] [Related]
5. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
Klecker RW; Cysyk RL; Collins JM
Bioorg Med Chem; 2006 Jan; 14(1):62-6. PubMed ID: 16143537
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401.
Zhang JW; Deng HB; Zhang CY; Dai JQ; Li Q; Zheng QG; Wan HX; Yu HP; He F; Xu YC; Zhao S; Zhang JYJ
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):669-680. PubMed ID: 31030415
[TBL] [Abstract][Full Text] [Related]
7. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu
Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW
Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686
[TBL] [Abstract][Full Text] [Related]
8. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
Crouch RD; Hutzler JM; Daniels JS
Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
[TBL] [Abstract][Full Text] [Related]
9. Refinement of In Vitro Methods for Identification of Aldehyde Oxidase Substrates Reveals Metabolites of Kinase Inhibitors.
Dick RA
Drug Metab Dispos; 2018 Jun; 46(6):846-859. PubMed ID: 29615437
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of c-Met Kinase Inhibitors Containing Quinoline by Aldehyde Oxidase, Electron Donating, and Steric Hindrance Effect.
Zhang JW; Xiao W; Gao ZT; Yu ZT; Zhang JYJ
Drug Metab Dispos; 2018 Dec; 46(12):1847-1855. PubMed ID: 30209037
[TBL] [Abstract][Full Text] [Related]
11. The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5.
Morrison RD; Blobaum AL; Byers FW; Santomango TS; Bridges TM; Stec D; Brewer KA; Sanchez-Ponce R; Corlew MM; Rush R; Felts AS; Manka J; Bates BS; Venable DF; Rodriguez AL; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA; Daniels JS
Drug Metab Dispos; 2012 Sep; 40(9):1834-45. PubMed ID: 22711749
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.
Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S
Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors.
Hutzler JM; Yang YS; Brown C; Heyward S; Moeller T
Drug Metab Dispos; 2014 Jun; 42(6):1090-7. PubMed ID: 24713130
[TBL] [Abstract][Full Text] [Related]
14. Inter-strain variability in aldehyde oxidase activity in the mouse.
Al-Salmy HS
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jul; 132(3):341-7. PubMed ID: 12161167
[TBL] [Abstract][Full Text] [Related]
15. Individual variation in hepatic aldehyde oxidase activity.
Al-Salmy HS
IUBMB Life; 2001 Apr; 51(4):249-53. PubMed ID: 11569919
[TBL] [Abstract][Full Text] [Related]
16. Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions.
Behera D; Pattem R; Gudi G
Xenobiotica; 2014 Aug; 44(8):722-33. PubMed ID: 24533630
[TBL] [Abstract][Full Text] [Related]
17. Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
Adusumalli S; Jamwal R; Obach RS; Ryder TF; Leggio L; Akhlaghi F
Drug Metab Dispos; 2019 Aug; 47(8):874-882. PubMed ID: 31182423
[TBL] [Abstract][Full Text] [Related]
18. Inter-species variation in the metabolism and inhibition of N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase.
Schofield PC; Robertson IG; Paxton JW
Biochem Pharmacol; 2000 Jan; 59(2):161-5. PubMed ID: 10810450
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.
Choughule KV; Barr JT; Jones JP
Drug Metab Dispos; 2013 Oct; 41(10):1852-8. PubMed ID: 23918666
[TBL] [Abstract][Full Text] [Related]
20. Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity.
Vassallo JD; Hicks SM; Daston GP; Lehman-McKeeman LD
Toxicol Sci; 2004 Aug; 80(2):249-57. PubMed ID: 15141102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
